CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease [Phase 1]

Phase 1 safety study update of AAB-003 (PF-05236812) in Alzheimer's disease. Results have been posted following completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2017-02-23